Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction
- PMID: 7599072
- PMCID: PMC2034130
- DOI: 10.1038/bjc.1995.283
Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction
Abstract
Recently, Ewing's tumours have been shown to carry specific hybrid transcripts resulting from the fusion of the EWS gene with FLI-1 or ERG genes. Based on the sensitivity and specificity of the detection of these alterations by the reverse transcriptase-polymerase chain reaction technique, we have developed an assay to search for small numbers of Ewing cells in various sites from patients with Ewing's tumour. This method enables the detection of fewer than one tumour cell per million blood mononuclear cells. A total of 28 primary sites and 51 peripheral samples from 36 patients were investigated. Tumour cells could be detected in 4/18 blood samples, 4/15 bone marrow aspirates and 2/18 peripheral stem cell harvests. EWS/FLI-1 and EWS/ERG transcripts being observed in eight and two cases respectively. The type of fusion transcript detected in peripheral site(s) was identical to that observed in the primary site. At diagnosis 5/16 patients (31%) demonstrated either circulating tumour cells or/and occult bone marrow metastasis. After induction therapy, tumour cells were detected in 3/21 patients. This highly sensitive method should be a relevant tool to allow a more accurate clinical assessment of the dissemination of Ewing's tumours.
Similar articles
-
In situ reverse-transcriptase polymerase chain reaction demonstration of the EWS/FLI-1 fusion transcript in Ewing's sarcomas and peripheral primitive neuroectodermal tumors.Virchows Arch. 2000 Sep;437(3):234-40. doi: 10.1007/s004280000252. Virchows Arch. 2000. PMID: 11037342
-
EWS/FLI-1 fusion transcript detection and MIC2 immunohistochemical staining in the diagnosis of Ewing's sarcoma.Pediatr Pathol Lab Med. 1996 May-Jun;16(3):379-92. doi: 10.1080/15513819609168678. Pediatr Pathol Lab Med. 1996. PMID: 9025840
-
EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma.Eur J Cancer. 1997 Feb;33(2):239-43. doi: 10.1016/s0959-8049(96)00463-7. Eur J Cancer. 1997. PMID: 9135495
-
Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.Curr Top Microbiol Immunol. 1997;220:143-50. Curr Top Microbiol Immunol. 1997. PMID: 9103680 Review. No abstract available.
-
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: Report of a case diagnosed by fine needle aspiration cytology and confirmed by immunocytochemistry and RT-PCR along with review of literature.Diagn Cytopathol. 2012 Aug;40 Suppl 2:E156-61. doi: 10.1002/dc.21717. Epub 2011 May 4. Diagn Cytopathol. 2012. PMID: 21548122 Review.
Cited by
-
Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.J Clin Pathol. 2003 Feb;56(2):96-102. doi: 10.1136/jcp.56.2.96. J Clin Pathol. 2003. PMID: 12560386 Free PMC article. Review.
-
Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.Cancer. 2011 Jan 1;117(1):86-95. doi: 10.1002/cncr.25522. Epub 2010 Aug 24. Cancer. 2011. PMID: 20737575 Free PMC article.
-
Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?Biomedicines. 2021 Sep 26;9(10):1315. doi: 10.3390/biomedicines9101315. Biomedicines. 2021. PMID: 34680432 Free PMC article. Review.
-
Progress in the molecular biology of ewing tumors.Sarcoma. 1998;2(1):3-17. doi: 10.1080/13577149878109. Sarcoma. 1998. PMID: 18521227 Free PMC article.
-
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.Clin Cancer Res. 2016 Jul 15;22(14):3643-50. doi: 10.1158/1078-0432.CCR-15-2516. Epub 2016 Feb 9. Clin Cancer Res. 2016. PMID: 26861456 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources